<DOC>
	<DOCNO>NCT01351766</DOCNO>
	<brief_summary>Evidence suggest significant percentage adolescent regular smoker interested try quit smoke frequently make attempt quit , yet unsuccessful maintain abstinence . Despite genuine desire quit part many adolescent , increase incidence smoking among old adolescent run counter overall trend smoke reduction see general population . Unfortunately , psychosocial pharmacological smoking intervention yet indicate clear effectiveness youth . Moreover , depression-related vulnerability , particularly currently elevate depressive symptom , highly comorbid smoke behavior dramatically reduce cessation rate . As result , new approach smoke cessation need adolescent smoker currently elevate depressive symptom . Thus objective present study develop specialized behavioral activation treatment smoke youth age 18-21 elevated depressive symptom . In first phase utilize focus group pilot test 15 youth develop behavioral activation smoking treatment youth ( BATSY ) . In Phase II , conduct open-label trial BATSY plus nicotine replacement therapy 30 youth also take part neuroimaging protocol examine reward sensitivity . Participants follow 26 week post-quit date .</brief_summary>
	<brief_title>Behavioral Activation Intervention , Reward Processing , Youth Smoking Cessation</brief_title>
	<detailed_description>This Open-label trial examine efficacy behavioral activation treatment smoking-youths ( BATSY ) . After complete focus group phase pilot study phase BATSY 15 youth , recruit 30 adolescent smoker elevate depressive symptom age 18-21 open-label trial BATSY treatment . All participant open-label trial receive 8 week transdermal nicotine patch addition BATSY intervention . Participants also undergo fMRI session include behavioral task assess reward sensitivity prior commencement BATSY intervention . We intend examine abstinence relapse outcome . In addition examine extent depressive symptom reward sensitivity prior quit date correspond improve smoking cessation outcome time .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<criteria>18 21 year age regular smoker least 6 month currently smoke average least 5 cigarette per day want quit smoke report current elevate depressive symptom current Axis I disorder psychoactive substance dependence ( exclude nicotine dependence ) within past 6 month current use psychotropic medication participation form psychotherapy history significant medical condition ( e.g. , cardiovascular , neurological , gastrointestinal ) , pregnancy and/or breast feeding , systemic illness limit mental competency [ Mini Mental State Examination score &lt; 23 ] and/or inability give inform , voluntary , write consent participate current use pharmacotherapy smoke cessation provide researcher quit attempt Additional fMRI Exclusion criterion : cerebrovascular disease high blood pressure diabetes use psychotropic medication 3 week prior participation fMRI protocol exposure extreme trauma lifetime history mania , psychosis , pervasive developmental disorder , ambidextrous leave handed metal implant , heart pacemaker , permanent retainer tattoo contain metal dye claustrophobia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Behavioral Activation</keyword>
</DOC>